Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice

被引:53
作者
Gomeza, J
Zhang, L
Kostenis, E
Felder, CC
Bymaster, FP
Brodkin, J
Shannon, H
Xia, B
Duttaroy, A
Deng, CX
Wess, J
机构
[1] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA
[2] NIDDKD, Biochem & Metab Lab, Bethesda, MD 20892 USA
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
gene targeting; oxotremorine; analgesia; locomotor activity; striatum; Parkinson's disease; dopamine receptor;
D O I
10.1016/S0024-3205(01)01039-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Muscarinic acetylcholine receptors (M-1-M-5) play important roles in the modulation of many key functions of the central and peripheral nervous system. To explore the physiological roles of the two G(i)-coupled muscarinic receptors, we disrupted the M-2 and M-4 receptor genes in mice by using a gene targeting strategy, pharmacological and behavioral analysis of the resulting mutant mice showed that the M-2 receptor subtype is critically involved in mediating three of the most striking central muscarinic effects, tremor, hypothermia, and analgesia. These studies also indicated that M-4 receptors are not critically involved in these central muscarinic responses. However, M-4 receptor-deficient mice showed an increase in basal locomotor activity and greatly enhanced locomotor responses following drug-induced activation of D1 dopamine receptors, This observation is consistent with the concept that M-4 receptors exert inhibitory control over D1 receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons where the two receptors are known to be coexpressed. These findings emphasize the usefulness of gene targeting approaches to shed light on the physiological and pathophysiological roles of the individual muscarinic receptor subtypes. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2457 / 2466
页数:10
相关论文
共 23 条
[1]  
[Anonymous], TRENDS NEUROSCI
[2]  
BERNARD V, 1992, J NEUROSCI, V12, P3591
[3]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[4]   Muscarinic receptor ligands and their therapeutic potential [J].
Eglen, RM ;
Choppin, A ;
Dillon, MP ;
Hegde, S .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :426-432
[5]  
Ellis JL, 1999, J PHARMACOL EXP THER, V288, P1143
[6]   Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice [J].
Gomeza, J ;
Shannon, H ;
Kostenis, E ;
Felder, C ;
Zhang, L ;
Brodkin, J ;
Grinberg, A ;
Sheng, H ;
Wess, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1692-1697
[7]   Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice [J].
Gomeza, J ;
Zhang, L ;
Kostenis, E ;
Felder, C ;
Bymaster, F ;
Brodkin, J ;
Shannon, H ;
Xia, B ;
Deng, CX ;
Wess, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10483-10488
[8]   Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice [J].
Hamilton, SE ;
Loose, MD ;
Qi, M ;
Levey, AI ;
Hille, B ;
McKnight, GS ;
Idzerda, RL ;
Nathanson, NM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13311-13316
[9]  
HARTVIG P, 1989, TRENDS PHARM SCI S, V10, P75
[10]  
HERSCH SM, 1994, J NEUROSCI, V14, P3351